Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-016908
Filing Date
2015-02-20
Accepted
2015-02-20 18:36:28
Documents
1
Period of Report
2015-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5563
  Complete submission text file 0001209191-15-016908.txt   7255
Mailing Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302
Business Address 23622 CALABASAS ROAD SUITE 300 CALABASAS CA 91302 818-264-2300
ImmunoCellular Therapeutics, Ltd. (Issuer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21900 BURBANK BOULEVARD 3RD FLOOR WOODLAND HILLS CA 91367
Business Address
Gengos Andrew (Reporting) CIK: 0001563623 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35560 | Film No.: 15637156